ArticleCancers2022

Assessment of Patient Reported Outcomes (PROs) in Outpatients Taking Oral Anticancer Drugs Included in the Real-Life Oncoral Program.

Bastien Collomb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.